Phase IIa trial of fingolimod for amyotrophic lateral sclerosis demonstrates acceptable acute safety and tolerability
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phase IIa trial of fingolimod for amyotrophic lateral sclerosis demonstrates acceptable acute safety and tolerability
Authors
Keywords
-
Journal
MUSCLE & NERVE
Volume 56, Issue 6, Pages 1077-1084
Publisher
Wiley
Online
2017-06-30
DOI
10.1002/mus.25733
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral Sclerosis
- (2016) Rosa Luisa Potenza et al. Neurotherapeutics
- Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: Assessed with [11C]-PBR28
- (2015) Nicole R. Zürcher et al. NeuroImage-Clinical
- Long-term survival in amyotrophic lateral sclerosis: A population-based study
- (2014) Elisabetta Pupillo et al. ANNALS OF NEUROLOGY
- A Neurodegeneration-Specific Gene-Expression Signature of Acutely Isolated Microglia from an Amyotrophic Lateral Sclerosis Mouse Model
- (2013) Isaac M. Chiu et al. Cell Reports
- Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival
- (2012) Jenny S. Henkel et al. EMBO Molecular Medicine
- Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS
- (2012) Oleg Butovsky et al. JOURNAL OF CLINICAL INVESTIGATION
- Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms
- (2012) Weihua Zhao et al. NEUROBIOLOGY OF DISEASE
- Peripheral nerve inflammation in ALS mice: cause or consequence
- (2012) O. Kano et al. NEUROLOGY
- Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis
- (2011) David R. Beers et al. BRAIN
- Excess Circulating Alternatively Activated Myeloid (M2) Cells Accelerate ALS Progression While Inhibiting Experimental Autoimmune Encephalomyelitis
- (2011) Ilan Vaknin et al. PLoS One
- Immunosuppressive treatment of patients with amyotrophic lateral sclerosis
- (2010) L. Werdelin et al. ACTA NEUROLOGICA SCANDINAVICA
- Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice
- (2010) David R. Beers et al. BRAIN BEHAVIOR AND IMMUNITY
- From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis
- (2010) John M Lincecum et al. NATURE GENETICS
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Amyotrophic lateral sclerosis
- (2009) Lokesh C Wijesekera et al. Orphanet Journal of Rare Diseases
- Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice
- (2009) I. M. Chiu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started